Altamira Gold (EQTRF) has announced a maiden mineral resource estimate for its Maria Bonita porphyry gold deposit within the Cajueiro Project in Brazil The open-pit resource includes Indicated Resources of 24.19Mt @ 0.46g/t gold (357,800oz) and Inferred Resources of 25.64Mt @ 0.44g/t gold (362,400oz) at a 0.2 g/t gold cut-off grade A higher-grade near-surface resource using a 0.5 g/t cut-off comprises Indicated Resources of 7.56Mt @ 0.72g/t gold (176,250oz) and Inferred Resources of 5.18Mt @ 0.92g/t gold (152,940oz) with mineralization extending to surface and a favorable waste-to-mineralized material ratio of 0.5:1 Maria Bonita is the first of nine porphyry-gold targets identified within the Cajueiro district The company plans to continue drilling to expand Maria Bonita and test the eight other targets Altamira Gold (EQTRF) ha annunciato una prima stima delle risorse minerarie per il suo giacimento di oro porfirico Maria Bonita situato all'interno del Progetto Cajueiro in Brasile La risorsa a cielo aperto comprende Risorse Indicate di 24,19 Mt @ 0,46 g/t oro (357.800 oz) e Risorse Inferred di 25,64 Mt @ 0,44 g/t oro (362.400 oz) con un cut-off di 0,2 g/t oro Una risorsa di qualità superiore vicino alla superficie comprende Risorse Indicate di 7,56 Mt @ 0,72 g/t oro (176.250 oz) e Risorse Inferred di 5,18 Mt @ 0,92 g/t oro (152.940 oz) con mineralizzazione che arriva fino alla superficie e un favorevole rapporto tra materiale di scarto e mineralizzato di 0,5:1 Maria Bonita è il primo di nove obiettivi di oro porfirico individuati nel distretto di Cajueiro L'azienda intende proseguire con le perforazioni per espandere Maria Bonita e testare gli altri otto obiettivi Altamira Gold (EQTRF) ha anunciado una estimación inicial de recursos minerales para su depósito de oro porfídico Maria Bonita dentro del Proyecto Cajueiro en Brasil El recurso a cielo abierto incluye Recursos Indicados de 24,19 Mt @ 0,46 g/t oro (357.800 oz) y Recursos Inferidos de 25,64 Mt @ 0,44 g/t oro (362.400 oz) con un límite de corte de 0,2 g/t oro Un recurso de mayor ley cerca de la superficie comprende Recursos Indicados de 7,56 Mt @ 0,72 g/t oro (176.250 oz) y Recursos Inferidos de 5,18 Mt @ 0,92 g/t oro (152.940 oz) El depósito permanece abierto hacia el oeste con mineralización que llega a la superficie y una favorable proporción de material de desecho a mineralizado de 0,5:1 Maria Bonita es el primero de nueve objetivos de oro porfídico identificados en el distrito Cajueiro La compañía planea continuar con los taladros para expandir Maria Bonita y probar los otros ocho objetivos Altamira Gold(EQTRF)는 브라질 Cajueiro 프로젝트 내 Maria Bonita 포르피리 금 광산에 대한 최초의 광물 자원 추정치를 발표했습니다 노천 자원에는 0.2 g/t 금 컷오프 등급에서 지정 자원 24.19Mt @ 0.46g/t 금 (357,800온스)와 추정 자원 25.64Mt @ 0.44g/t 금 (362,400온스)가 포함됩니다 0.5 g/t 컷오프를 적용한 고품위 근표면 자원은 지정 자원 7.56Mt @ 0.72g/t 금 (176,250온스)와 추정 자원 5.18Mt @ 0.92g/t 금 (152,940온스)로 구성됩니다 광물화가 표면까지 확장되고 폐석 대비 광물화 물질 비율이 0.5:1로 유리합니다 Maria Bonita는 Cajueiro 지구 내 확인된 아홉 개의 포르피리 금 목표 중 첫 번째입니다 회사는 Maria Bonita 확장과 나머지 여덟 목표를 시험하기 위해 시추를 계속할 계획입니다 Altamira Gold (EQTRF) a annoncé une première estimation des ressources minérales pour son gisement d’or porphyrique Maria Bonita dans le cadre du projet Cajueiro au Brésil La ressource à ciel ouvert comprend des ressources indiquées de 24,19 Mt à 0,46 g/t d’or (357 800 oz) et des ressources inférées de 25,64 Mt à 0,44 g/t d’or (362 400 oz) avec un seuil de coupure de 0,2 g/t d’or Une ressource de meilleure qualité proche de la surface comprend des ressources indiquées de 7,56 Mt à 0,72 g/t d’or (176 250 oz) et des ressources inférées de 5,18 Mt à 0,92 g/t d’or (152 940 oz) avec une minéralisation atteignant la surface et un ratio favorable de matériaux stériles par rapport aux matériaux minéralisés de 0,5:1 Maria Bonita est la première des neuf cibles d’or porphyrique identifiées dans le district de Cajueiro La société prévoit de poursuivre les forages pour étendre Maria Bonita et tester les huit autres cibles Altamira Gold (EQTRF) hat eine erste Mineralressourcenschätzung für seine Maria Bonita Porphyr-Goldlagerstätte im Cajueiro-Projekt in Brasilien bekannt gegeben Die Tagebau-Ressource umfasst angezeigte Ressourcen von 24,19 Mio t mit 0,46 g/t Gold (357.800 Unzen) und abgeleitete Ressourcen von 25,64 Mio t mit 0,44 g/t Gold (362.400 Unzen) bei einem Gold-Schnittwert von 0,2 g/t Eine höherwertige oberflächennahe Ressource mit einem Schnittwert von 0,5 g/t umfasst angezeigte Ressourcen von 7,56 Mio t mit 0,72 g/t Gold (176.250 Unzen) und abgeleitete Ressourcen von 5,18 Mio und einem günstigen Verhältnis von Abraum zu mineralisiertem Material von 0,5:1 Maria Bonita ist das erste von neun Porphyr-Goldzielen die im Cajueiro-Distrikt identifiziert wurden um Maria Bonita zu erweitern und die acht weiteren Ziele zu testen (TSXV: ALTA) (FSE: T6UP) (OTC Pink: EQTRF) ("Altamira" or the "Company") is pleased to announce the results of an independently assessed maiden mineral resource estimate for the Maria Bonita porphyry gold deposit within the Cajueiro Project the Cajueiro Central Mineral Resource (previously reported under NI 43-101) CEO Mike Bennett commented; "We are thrilled with the maiden mineral resource estimate for our Maria Bonita project This is a transformational step forward for the company and together with the existing resources at Cajueiro doubles Altamira's Indicated and Inferred resource base The mineralization at Maria Bonita is notably coherent and regular with higher grades returned from near surface material Coupled with our portfolio of nine drill-ready targets within the Cajueiro district we now have an excellent opportunity to add to these resources through both the expansion of the defined mineral resources at both Maria Bonita and Cajueiro Central and additional discoveries of porphyry-related mineralization in the district We will be mobilising a drill rig shortly to continue testing of the extensions to the Maria Bonita mineralization and our district targets We look forward to the continued delineation of the deposit and unlocking the potential of the other eight targets." The Cajueiro project is located approximately 75km NW of the town of Alta Floresta in the state of Mato Grosso (Figure 1) in central western Brazil lies on open farmland and has grid power and a local water supply (Figure1) To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/4500/250784_7bf8a4c5340228dd_001full.jpg The Cajueiro Central project has current NI 43-101 resources* of 5.66Mt @ 1.02 g/t gold for a total of 185,000 oz in the Indicated Resource category and 12.66Mt @ 1.26 g/t gold for a total of 515,000 oz in the Inferred Resource category (estimated using a gold price of US$1,500/oz) The maiden mineral resource estimate for Maria Bonita was completed by VMG Consultoria e Soluções Ltda of Belo Horizonte Brazil under the direction of Volodymyr Myadzel PhD The estimate is based on drilling undertaken by Altamira between August 2022 and April 2024 A total of thirty-one diamond drillholes (4,710m) have been completed at the Maria Bonita target twenty-nine drill holes were used to estimate the mineral resource (4,518m) The parameters used to constrain a pit shell in the mineral resource estimate process are presented in Table 1 The resource estimations are based on a block model interpolated by the Ordinary Kriging (OK) method The block model was created using wireframes and filled with blocks measuring 25 (X) by 25 (Y) by 10 (Z) metres The radii and the orientation of the search ellipses were determined using standard variograms All Inferred Resources and Indicated Resources are defined in accordance with the Canadian Institute of Mining Metallurgy and Petroleum Definition Standards for Mineral Resources and Mineral Reserves (2014) (the "CIM Standards") a wireframe that encompasses the area with a 50×50 and 50×100 metre regular drilling grid was created an average of 3 holes and 8 composite samples were used The other blocks were classified as Inferred Resources The block model was validated in several ways: by running an Inverse Distance Weighted interpolation and comparing the results and by comparing the means and standard deviations of the block grades to the composite data set an open pit mining configuration was used and an agitated leach gold recovery was assumed Industry standard assumptions on unit costs and other parameters were applied Table 1: Maria Bonita independent Mineral Resource estimate parameters To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/4500/250784_altamiratable1.jpg Open-pit Indicated Resources are 24.19Mt @ 0.46g/t (for a total of 357,800oz) and Total Inferred Resources are 25.64Mt @ 0.44g/t (for a total of 362,400oz) These resources include near-surface saprolite Indicated resources of 2,02Mt @ 0.59g/t (for a total of 38,000oz) and Inferred Resources of 0.68t @ 0.40g/t (for a total of 8,700oz) These resources were calculated using a 0.2 g/t gold cut-off grade and were estimated for the volume of mineralized material drill tested to date Of particular importance in the resource estimate is the uniform style of mineralization and the regular grade distribution To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/4500/250784_altamiratable2.jpg Numbers may not add due to rounding Mineral Resources that are not Mineral Reserves do not have demonstrated economic viability.Table 2: Maria Bonita Mineral Resource at a 0.2g/t gold cut-off grade A significant higher grade near-surface resource has also been identified and at a 0.5 g/t gold cut-off comprises total Indicated Resources of 7.56Mt @ 0.72g/t (for a total of 176,250oz) and Total Inferred Resources are 5.18Mt @ 0.92g/t (for a total of 152,940oz) - Table 3 Table 3: Maria Bonita Mineral Resource sensitivity to gold cut-off grade To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/4500/250784_altamiratable3.jpg The Maria Bonita porphyry gold deposit is part of a district-scale There are currently eight additional porphyry gold targets over a strike of 12km east-west awaiting scout drill testing (Figure 2) Figure 2: Maria Bonita maiden mineral resource in relation to the Cajueiro Central mineral resource which comprises 185,000 ounces of gold in the Indicated category (5.66Mt @ 1.02 g/t) and an additional 515,000 ounces in the Inferred category (12.66Mt @ 1.26 g/t) Untested district drill targets are depicted by yellow labels To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/4500/250784_7bf8a4c5340228dd_005full.jpg a consultant to the Company as well as a Qualified Person as defined by National Instrument 43-101 supervised the preparation of the technical information in this news release Further details supporting the geological model, estimation procedure and block modeling will be available in a National Instrument 43-101 Technical Report authored by Volodymyr Myadzel, PhD, MAIG, of VMG Consultoria e Soluções Ltda of Belo Horizonte, Minas Gerais, Brazil. The report will be posted under the Altamira profile at www.sedarplus.ca within 45 days from the date of this news release The Company is focused on the exploration and development of gold and copper projects within western central Brazil strategically advancing six projects spanning over 100,000 hectares within the prolific Juruena Gold Belt—an area that has historically yielded over 6 million ounces of placer gold** Leading the portfolio is the Cajueiro project a highly prospective asset with an NI 43-101 compliant resource estimate of 185,000 ounces of gold in the Indicated category (5.66Mt @ 1.02 g/t) and an additional 515,000 ounces in the Inferred category (12.66Mt @ 1.26 g/t) Ongoing exploration and fieldwork at Cajueiro indicate the presence of multiple porphyry gold systems reinforcing its potential for district-scale development These hard-rock gold sources align with historical alluvial gold production highlighting the region's exceptional gold endowment and scalability With a rich geological setting and a track record of significant discoveries the Company is well-positioned to unlock further value across its expansive land package Tel: 604.676.5660Toll-Free:1-833-606-6271info@altamiragold.comwww.altamiragold.com Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release The securities described herein have not been registered under the U.S Securities Act or any state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements under the U.S Securities Act and any applicable state securities laws Certain information contained herein constitutes "forward-looking information" under Canadian securities legislation statements with respect to the extension of the Warrants forward-looking information can be identified by the use of forward-looking terminology such as "will" "intends" or variations of such words and phrases or statements that certain actions Forward-Looking statements are based on the opinions and estimates of management as of the date such statements are made and they are subject to known and unknown risks uncertainties and other factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements or forward-looking information including the receipt of all necessary regulatory approvals Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information there may be other factors that cause results not to be as anticipated There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements readers should not place undue reliance on forward-looking statements and forward-looking information The Company will not update any forward-looking statements or forward-looking information that is incorporated by reference herein except as required by applicable securities laws Gold analysis has been conducted by SGS method FAA505 (fire assay of 50g charge) with higher grade samples checked by FAA525 Analytical quality is monitored by certified references and blanks samples are stored under the supervision the Company's exploration office The samples are couriered to the assay laboratory using a commercial contractor Pulps are returned to the Company and archived Drill holes results are quoted as down-hole length weighted intersections To view the source version of this press release, please visit https://www.newsfilecorp.com/release/250784 Already have an account? Login Altamira Gold Corp ( (TSE:ALTA) ) has provided an update Altamira Gold Corp has announced a maiden mineral resource estimate for the Maria Bonita porphyry gold deposit within the Cajueiro Project in Brazil The estimate reveals significant indicated and inferred resources with the potential for expansion as the deposit remains open in several directions This development doubles Altamira’s resource base and positions the company to enhance its operations and industry standing The company plans further drilling to expand the Maria Bonita resources and explore additional targets within the district indicating a strategic move to strengthen its market position and offer promising prospects for stakeholders According to Spark, TipRanks’ AI Analyst Altamira Gold Corp has significant challenges with profitability and cash flow due to zero revenue but it benefits from a strong balance sheet The technical analysis suggests a neutral to mildly positive trend but the valuation is weak due to ongoing losses Recent positive developments in exploration projects offer potential for future growth but the overall financial state remains a critical weakness To see Spark’s full report on TSE:ALTA stock, click here Altamira Gold Corp is a company operating in the mining industry focusing on the exploration and development of gold deposits The company is primarily engaged in identifying and expanding mineral resources with a market focus on gold mining projects in Brazil For an in-depth examination of ALTA stock, go to TipRanks’ Stock Analysis page Disclaimer & DisclosureReport an Issue Altamira Gold Corp ( (TSE:ALTA) ) has provided an update According to Spark, TipRanks’ AI Analyst Disclaimer & DisclosureReport an Issue (OTC: EQTRF) has released its maiden mineral resource estimate for the Maria Bonita porphyry gold deposit consists of indicated resources of 24.19 million tonnes grading 0.46 g/t gold and inferred resources of 25.64 million tonnes grading 0.44 g/t gold a higher-grade near-surface resource has been identified at a cut-off of 0.5 g/t gold This includes indicated resources of 7.56 million tonnes grading 0.72 g/t gold (176,250 ounces) and inferred resources of 5.18 million tonnes grading 0.92 g/t gold (152,940 ounces) This newfound potential highlights the attractiveness of the project The Maria Bonita deposit remains open for expansion to the west and the deposit exhibits a favorable strip ratio of 0.5:1 Altamira Gold has identified eight more prospective porphyry gold targets within the Cajueiro district Located approximately 75 km northwest of Alta Floresta in Mato Grosso the Cajueiro project benefits from excellent infrastructure facilitating ongoing exploration and expansion activities We changed the address of the Stockhouse website from www.stockhouse.com to stockhouse.com When this page refreshes you will be logged in with the new address If you have JavaScript enabled then this page should refresh automatically if it does not then please tap the button below Proceed to Stockhouse (“Altamira” or the “Company”) (OTCQB:CYTOF) a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver today provided a business update and reported its full year 2024 financial results "Altamira made great progress in its core business of RNA delivery in 2024," commented Thomas Meyer "The successful testing of our xPhore platform with circular RNA was just one major achievement among many others We look forward to developing and supplying innovative nanoparticles to partners in pharma and biotech for the safe and effective delivery of various types of RNA molecules to targets beyond the liver To maximize the potential of our RNA delivery business we took the first steps towards partially spinning it off to private equity investors We intend to complete this process in the coming months.” Altamira made further progress with the development of its peptide based xPhore™ nanoparticle platform The technology allows for extrahepatic RNA delivery the nanoparticles disassemble and release their RNA payload at substantially higher rates than lipid nanoparticles (LNPs) part of the Company’s expanding research and development team moved to the Switzerland Innovation Park in Allschwil near Basel the Company has access to modern and well-equipped lab facilities to support its growing activities The key focus for the development activities has been on nanoparticle formulation and process development for nanoparticle manufacturing Important progress was achieved with the development and refinement of analytical methods the reproducibility of manufacturing and stability of the nanoparticles the xPhore™ platform was successfully tested also for circular mRNA (circRNA) In vitro experiments demonstrated successful transfection of cells and significantly higher protein expression than with linear mRNA based on which the Company filed a provisional patent application with the United States Patent Office (USPTO) CircRNA has been attracting substantial interest in drug development thanks to enhanced protein expression and greater stability compared to linear mRNA Altamira is pursuing with the RNA delivery business a ‘picks and shovels’ strategy based on the licensing of its xPhore™ platform technology to partners in the biotech and pharma industry for use in their own RNA drug product development programs The platform is adapted for the specific requirements of different RNA modalities: OligoPhore™ for oligonucleotides the Company has set up collaborations with three partners Altamira expects to sign up at least two more partners in the course of 2025 The Company intends to grow the RNA delivery business which it operates through its Swiss subsidiary Altamira Therapeutics AG (“ATAG”) by involving private equity investors for its funding Altamira aims to spin off a majority of ATAG’s share capital and has initiated the process for the legal and organizational carve-out of the entity Altamira made further progress also with its non-core activities (“legacy assets”) The Company’s associate Altamira Medica AG (“Medica”) preservative free nasal spray for the treatment of allergic rhinitis agreed with two of its international distributors on the expansion of their exclusive distribution territories (Southeast Asia Marketing approval for Mainland China is expected for 2025 With the USPTO’s allowance of a patent covering the composition of Bentrio® a major milestone was reached for the intended US commercialization Bentrio® has already been cleared by the FDA and shall be marketed in the US through a licensing partner; discussions are ongoing Medica is in the process of transitioning Bentrio® from a Class I to a Class IIa medical device under the new EU Medical Device Regulation (MDR) Partnering discussions are also ongoing regarding AM-125 a patented nasal spray for the treatment of acute vestibular syndrome (AVS) which may be developed also for various other disorders of the central nervous system which in the traditional oral formulation is the standard of care treatment for vertigo in many countries around the world Further legacy assets intended for partnering include AM-111 a cell-penetrating peptide for the treatment of acute hearing loss which has orphan drug designation and is in Phase 3 clinical development an oral small molecule for the treatment of tinnitus (preclinical stage) Full Year 2024 Financial Results and Outlook Following the partial divestiture of the Bentrio® business in November 2023 related activities were reclassified and reported as discontinued operations for the time up to the transaction Continuing operations comprise the RNA delivery development programs as well as those related to AM-125 Upon completion of the planned partial spin-off of its ATAG subsidiary Altamira expects its operating expenses to decrease significantly The Company expects to fund its operations from its cash position proceeds from the sale of ATAG shares to private equity investors the partnering or divestiture of legacy assets as well as from the provision of services for affiliates Altamira intends to update its financial guidance as and when material new information will become available notably on the planned partial spin-off of ATAG Altamira’s Senior Management will hold an investor call today EDT to present its business update and the Company’s full-year 2024 results A replay of the call will be available after the live event and accessible through the webcast link: Consolidated Statement of Profit or Loss and Other Comprehensive Income/(Loss)For the Years Ended December 31 (1) Amounts have been re-presented from those previously published to reflect the change in the Company’s presentation currency from Swiss francs to US dollars (2) Weighted average number of shares outstanding: 2024: 2,832,299; 2023: 491,258 Consolidated Statement of Financial PositionAs of December 31 Altamira Therapeutics (OTCQB:CYTOF) is developing and supplying peptide-based nanoparticle technologies for efficient RNA delivery to extrahepatic tissues (xPhore™ platform) The versatile delivery platform is suited for different RNA modalities and made available to pharma or biotech companies through out-licensing The Company has two proprietary flagship programs based on xPhore™ and siRNA payloads: AM-401 for KRAS driven cancer and AM-411 for rheumatoid arthritis both in preclinical development beyond in vivo proof of concept Altamira holds a 49% stake (with additional economic rights) in Altamira Medica AG which owns its commercial-stage legacy asset Bentrio® the Company is in the process of partnering / divesting its inner ear legacy assets visit: https://altamiratherapeutics.com/    This press release may contain statements that constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 Forward-looking statements are statements other than historical facts and may include statements that address future operating financial or business performance or Altamira’s strategies or expectations you can identify these statements by forward-looking words such as "may" or the negative of these terms or other comparable terminology Forward-looking statements are based on management's current expectations and beliefs and involve significant risks and uncertainties that could cause actual results developments and business decisions to differ materially from those contemplated by these statements Altamira’s need for and ability to raise substantial additional funding to continue the development of its product candidates the clinical utility of Altamira’s product candidates the timing or likelihood of regulatory filings and approvals Altamira’s intellectual property position and Altamira’s financial position including the impact of any future acquisitions license transactions or changes to Altamira’s capital structure These risks and uncertainties also include those described under the caption "Risk Factors" in Altamira’s Annual Report on Form 20-F for the year ended December 31 and in Altamira’s other filings with the Securities Exchange Commission (“SEC”) which are available free of charge on the SEC’s website at: www.sec.gov Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect actual results may vary materially from those indicated All forward-looking statements and all subsequent written and oral forward-looking statements attributable to Altamira or to persons acting on behalf of Altamira are expressly qualified in their entirety by reference to these risks and uncertainties You should not place undue reliance on forward-looking statements Forward-looking statements speak only as of the date they are made and Altamira does not undertake any obligation to update them in light of new information except as may be required under applicable law Hear@altamiratherapeutics.com LBV Magazine English Edition A recent study on the cave paintings of the Altamira Cave in Santillana del Mar Cantabria (Spain) has concluded that some of the artworks it contains could be much older than previously believed Although the cave was discovered more than 140 years ago the exact chronology of the artworks it contains has been a subject of debate among experts an international team of scientists has used advanced dating techniques to more precisely determine when they were created focused on analyzing small carbonate crusts that formed over the paintings similar to the calcite layers seen in some caves forming stalactites and stalagmites act as a kind of “time capsule,” as their formation can be dated thereby establishing a minimum age for the paintings they cover the scientists took minimal samples of these crusts using sterilized scalpels They then applied a method known as “uranium-series dating,” which measures the natural decay of chemical elements in the samples to calculate their age This method is less invasive than others like radiocarbon dating which requires destroying part of the pigment indicating that the symbol was created during the Aurignacian period one of the earliest phases of the Upper Paleolithic showed minimum ages of 22,600 and 32,020 years indicating that they were made during the Gravettian period or even earlier they have been obtained in an independent laboratory the team corrected possible errors caused by impurities in the samples The new data confirms the theory that the art in Altamira Cave was not created at a single moment Different generations of prehistoric artists left their mark in the cave from the earliest abstract symbols to the famous polychrome animal paintings of the Magdalenian period (around 14,000 years ago) The researchers found that from very early stages coexisted in the cave with abstract symbols contradicting the old theory that figurative art emerged after symbolic representations Both styles coexisted from the beginnings of the Upper Paleolithic The results confirm that the method is reliable and that the dates previously published were correct This is crucial not only for Altamira but also for other cave art sites around the world where similar techniques are applied The cave was closed to the public in 2002 to protect its paintings and today only limited access is allowed for experts although a replica cave outside can be visited Qingfeng Shao, Carmen de las Heras, et al., Art in red: New dates for paintings in the Cave of Altamira, Santillana del Mar, Spain. Journal of Archaeological Science, Volume 179, July 2025, 106235. doi.org/10.1016/j.jas.2025.106235 Subscribe to get the latest posts sent to your email Why did some animals from ancient eras become fossils while others simply disappeared without a trace A team of paleontologists from the University of Leicester has managed to decipher one of the many enigmas of the dinosaur era—the exact moment when pterosaurs Rome achieved numerous military victories that allowed it to grow and dominate nearly the entire known world in Antiquity In a city doomed to eternity by the fury of Vesuvius The most recent comes from the House of Helle… The fascination with figuring out the part that the Milky Way may have played in the culture and religion of ancient Egypt has led astrophysicist Dr A recent study published in Nature Astronomy has revealed that the dwarf galaxies orbiting around Andromeda are distributed in such an uneven way that it calls into… A team of researchers has analyzed more than 165 gold objects found in four monumental tombs in the Bay of Volos led by Professor Karen Hardy from the University of Glasgow has discovered evidence of what may be one of the earliest known human populations… The Chapel of Corpus Christi in the Toledo Cathedral is also known as the Mozarabic Chapel because Cardinal Cisneros decreed in 1504 that it be used to celebrate worship according… That program would continue the following month with Sputnik II Receive our news and articles in your email for free You can also support us with a monthly subscription and receive exclusive content 2025 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd ("Altamira" or the "Company") (OTCQB: CYTOF) today announced that it will host its Full Year 2024 Financial Results and Business Update Call on Wednesday and CEO Thomas Meyer and COO Covadonga Pañeda will deliver prepared remarks https://register-conf.media-server.com/register/BI95acee4618c44d05a56b78125b22638d  https://edge.media-server.com/mmc/p/7t3h98aw Investor ContactHear@altamiratherapeutics.com Read on for the main highlights of the call The company showcased significant progress in its RNA delivery business through new partnerships and patent filings despite challenges such as Nasdaq delisting and an increased net loss including engaging private equity investors and planning a spin-off for its RNA delivery activities indicate a proactive approach towards future growth Altamira has made notable strides in its RNA delivery business by securing two new partners for its xPhore platform This development underscores the platform’s versatility and opens up new business opportunities for the company The company expanded its horizons by entering into a new collaboration agreement with a firm in the radiopharmaceutical sector This partnership is expected to enhance Altamira’s capabilities in cancer treatment Altamira is on the verge of expanding its market reach for Bentrio nasal spray with marketing approval anticipated in Mainland China The company reported a significant reduction in cash used in operations decreasing from $12.8 million in 2023 to $6.1 million in 2024 This decrease reflects Altamira’s efforts to streamline its operations and manage resources efficiently Altamira filed a provisional patent application for CycloPhore with the U.S This move highlights the potential of CycloPhore in the circular RNA space further strengthening Altamira’s position in the market Altamira faced a setback with the delisting of its common shares from Nasdaq due to a minimum bid price issue This development has impacted the company’s ability to secure funding from public markets The company reported an increased net loss of $8.5 million for 2024 compared to $4.3 million in the previous year It’s important to note that 2023 included a profit from discontinued operations Shareholders’ equity saw a decline from $7.7 million at the end of 2023 to $6.6 million by the end of 2024 reflecting the financial challenges faced by Altamira Altamira provided forward-looking guidance indicating a slight increase in operating loss from continuing operations rising from $6.6 million in 2023 to $6.9 million in 2024 Research and development expenses increased while general and administrative expenses decreased The company anticipates a reduction in operating expenses following the partial spin-off of its RNA delivery subsidiary Altamira plans to fund future operations through existing cash Altamira Therapeutics Ltd.’s earnings call painted a picture of a company navigating through challenges while making strategic moves for future growth Despite the increased net loss and Nasdaq delisting the company is making significant progress in its RNA delivery business and expanding its market reach Altamira’s proactive strategies and forward-looking guidance suggest a commitment to overcoming current hurdles and achieving long-term success Altamira Therapeutics Ltd. ((CYTOF)) has held its Q4 earnings call Here is a breakdown of the information Altamira Therapeutics Ltd specializes in developing RNA delivery technology aimed at targets beyond the liver utilizing its innovative xPhore™ nanoparticle platform Altamira Therapeutics highlighted significant advancements in its RNA delivery business including successful testing of its xPhore platform with circular RNA and plans to partially spin off this segment to private equity investors Key financial metrics revealed an increase in operating loss from $6.6 million in 2023 to $6.9 million in 2024 while cash used in operations was reduced by more than half to $6.1 million The company ended the year with shareholders’ equity of $6.6 million and no financial debt Strategic collaborations were established with partners in the biotech and radiopharmaceutical sectors with expectations to expand partnerships further in 2025 Altamira also made progress with its legacy assets including the commercialization of Bentrio® and ongoing partnering discussions for other therapeutic products Altamira plans to continue expanding its RNA delivery business and expects to reduce operating expenses following the planned spin-off of its ATAG subsidiary The company aims to fund its operations through cash reserves and potential partnerships or divestitures of legacy assets Altamira Therapeutics Ltd. ( (CYTOF) ) has released its Q4 earnings (“Altamira” or the “Company”) (OTCQB: CYTOF) 2024 it received notice that the Nasdaq Hearings Panel (the "Panel") had determined to delist the Company's common shares from The Nasdaq Stock Market LLC ("Nasdaq") due to the Company's failure to comply with Rule 5550(a)(2) of Nasdaq’s Listing Rules The Rule requires listed securities to maintain a minimum bid price of $1.00 per share The Company's common shares will be delisted from Nasdaq at the open of trading on December 20 2024 and are expected to then begin trading on the OTCQB marketplace under the ticker symbol “CYTOF” ensuring uninterrupted market activity for its shareholders Shareholders will not need to take any action OTCQB is one of three marketplaces for trading over-the-counter (OTC) stocks operated by the OTC Markets Group the Company had received a delisting notification from Nasdaq on September 30 2024 and filed an appeal with the Panel to present its plan for regaining compliance The Panel denied the Company’s request to continue its listing on Nasdaq “While we are disappointed by the Panel’s decision which is a well-established and large marketplace for emerging growth companies,” commented Thomas Meyer “The transition from Nasdaq to OTCQB will allow us to focus on growing the Company based on our exciting RNA delivery platforms Since the $1 minimum bid price rule does not apply to OTCQB listed companies there is no requirement to perform any reverse stock split.” This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 Forward-looking statements can be identified by words such as “projects,” “may,” “will,” “could,” “would,” “should,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “potential,” “promise” or similar references to future periods Examples of forward-looking statements in this press release include statements regarding the Company’s plans with respect to the delisting of its common shares and the trading of the Company’s common shares Any forward-looking statements in this press release are based on management’s current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements Hear@altamiratherapeutics.com today announced that its nanoparticle-based delivery platform was successfully tested also for circular mRNA based on which the Company has filed a provisional patent application with the United States Patent Office (USPTO) Altamira will start offering its platform to biotech and pharma companies for use with circular RNA under the CycloPhore™ label complementing its offerings for siRNA (OligoPhore™) and mRNA (SemaPhore™) “We are very excited about the potential for CycloPhore as circular mRNA has been attracting great interest in drug development thanks to enhanced protein expression and greater stability compared to linear mRNA,” commented Covadonga Pañeda Altamira Therapeutics’ Chief Operating Officer circular mRNA could allow for lower dosing and less frequent administrations than linear mRNA which may be very important for certain therapeutic indications or vaccines CycloPhore provides further testimony to the versatility of our delivery platform across different RNA modalities We expect that the expansion of our platform into this exiting new RNA modality together with the platform’s ability to deliver extrahepatically and promote strong endosomal escape will make CycloPhore an attractive tool for drug developers looking for delivery vehicles that fit their specific needs.”   These risks and uncertainties include but are not limited to the clinical utility of Altamira’s product candidates Hear@altamiratherapeutics.com Altamira Therapeutics ( (CYTOF) ) just unveiled an announcement Altamira Therapeutics announced significant advancements in its RNA delivery business highlighting the successful testing of its xPhore platform with circular RNA and plans to partially spin off this segment to private equity investors The company also reported its full-year 2024 financial results noting a reduction in cash used for operations and an increase in net loss compared to the previous year including collaborations and potential spin-offs aim to strengthen its market position and attract further investment while ongoing developments in its legacy assets Altamira Therapeutics exhibits significant financial and operational challenges typical of early-stage biotechnology firms with notable weaknesses in revenue generation and cash flow management Technical indicators denote a strong bearish trend with the stock trading well below key moving averages and showing oversold conditions The lack of valuation metrics and earnings call insights adds to the uncertainty leading to a cautious and low overall stock score To see Spark’s full report on CYTOF stock, click here is a company focused on developing and commercializing RNA delivery technology The company operates in the biotechnology sector and is involved in creating innovative nanoparticle solutions for RNA molecule delivery aiming to collaborate with partners in the pharmaceutical and biotech industries Find detailed analytics on CYTOF stock on TipRanks’ Stock Analysis page Altamira Therapeutics ( (CYTOF) ) just unveiled an announcement today announced that it has entered into a collaboration agreement with a company in the radiopharmaceutical sector to evaluate the use of the Company’s proprietary RNA delivery platform for radiopharmaceutical targeting Radiopharmaceutical therapy uses tiny amounts of radioactive compounds (“radiopharmaceuticals” or “radioligands”) to diagnose and treat various diseases the radiopharmaceutical finds its way to the tumor through the bloodstream and binds to a tumor-specific receptor The global radiopharmaceutical market reached $8.4 billion in size in 2024 and is expected to grow to US$ 17.1 billion by 2033.1  Altamira and its project collaboration partner intend to test in vitro and in vivo the use of nanoparticles with an undisclosed RNA payload in conjunction with one of the partner’s proprietary radiopharmaceuticals Upon successful conclusion of the experiments have the option to negotiate with Altamira a license and supply agreement to develop and commercialize the RNA nanoparticles for use in cancer treatment “We are very delighted to initiate this collaboration to explore the utility of our RNA delivery technology in conjunction with radiopharmaceuticals” “The concept of radiopharmaceutical therapy has allowed for highly impressive advances in treatment outcomes and holds great promise for expanding precision oncology to additional tumor types We look forward to working with our partner on further enhancing radiopharmaceuticals’ therapeutic benefits.” Hear@altamiratherapeutics.com 1 https://straitsresearch.com/report/radioligand-therapy-market Monday - Friday 9am-12pm / 2pm-6pm GMT + 1 All financial news and data tailored to specific country editions Altamira Technologies has appointed Theodore Glusko, a defense industry veteran, as president The McLean, Virginia-based technology company said Tuesday Glusko will report directly to Altamira CEO Jane Chappell “Ted has worked his entire career across Altamira’s key Customers including both Intel and DoD as well as across both operations and development He has a strong track record of program performance and Customer relationships,” Chappell said Prior to Altamira, the newly appointed president spent 38 years at RTX including vice president of intelligence production solutions he was responsible for a $1.2 billion business within Raytheon Intelligence and Space segment material handling and data centers installation and operations The premier source of breaking business news for the government contracting industry to-the-point stories of the most significant contract awards M&A activities and financial results of the sector’s most notable players GovCon Wire is always on top of the most recent contracting sector activity and is updated in real time as the news breaks Important URLs: About us – Government Contracting FAQ – Guest Contributions – 2024 Events (OTCQB:CYTOF) today announced that the U.S Patent and Trademark Office ("USPTO") has issued a Notice of Allowance for a patent (application #17/466,142) relating to the composition of Bentrio® a nasal spray developed and commercialized by its affiliate Altamira Medica AG (“Medica”) for preventing or treating allergic rhinitis The claims are directed to the key ingredients and composition of Bentrio’s proprietary formulation will have an initial priority date of September 8 and is expected to provide key intellectual property protection for Bentrio in the USA the world’s largest market for “over the counter (OTC)” products for allergic rhinitis relief and treatment “We are very pleased to have achieved this major milestone in the protection of our intellectual property around Bentrio,” commented Thomas Meyer “Based on a drug free and preservative free formulation Bentrio has demonstrated significant alleviation of the classic nasal symptoms of allergic rhinitis and rhinorrhea as well as of ocular symptoms We look forward to making the product available in more and more countries and in particular also to allergy sufferers in North America through well established partners in the consumer health space.” Hear@altamiratherapeutics.com Natural gas price transparency & key data for the N Learn More: EOD natural gas forward price curves at 70+ key North American trading locations Forward curve prices of natural gas in North America Mexico natural gas pricing data & fundamentals Insight into tomorrow's natural gas prices and historical data Pricing and market developments for shale and unconventional plays and market developments for shale and unconventional plays Department of Energy (DOE) is allowing New Fortress Energy Inc to export up to 1.4 million metric tons/year of LNG to non-free trade agreement (FTA) countries from its recently commissioned Fast LNG facility in Mexico marking the first non-FTA permit granted this year DOE staff noted ongoing concerns about U.S including an ongoing study into the impacts of gas exports but ultimately concluded Fast LNG’s shipments to the international market were in the public interest “DOE is continuing to monitor market developments closely as the impact of successive authorizations of LNG exports and re-exports unfolds,” agency staff wrote in the order “DOE also acknowledges that proposals to re-export U.S.-sourced natural gas in the form of LNG from Mexico or Canada to non-FTA countries raise public interest considerations that are not present for domestic exports of LNG.” After becoming the first new North American LNG project to ship a commissioning cargo this year NFE’s project has also become the first test of DOE’s response to a recent court ruling In January, the Biden administration ordered DOE to halt considerations for pending non-FTA export permits while agency researchers compiled a market study on how the expansion of U.S LNG export capacity since 2016 has impacted domestic fundamentals Six months later, a federal court ruled that DOE overstepped its authority by halting the permit review process and ordered the agency to restart considerations for non-FTA licenses the decision initially raised more questions than answers as DOE retained most of its power to determine how long a review process can take The facility offshore of the Altamira coast was one of at least seven commercially advanced projects in the United States and Mexico that had a pending application for a non-FTA permit impacted by DOE’s pause on new authorizations NFE previously requested to re-export 145 Bcf/year, or 400 MMcf/d, from Texas through Altamira until 2050. It received partial authorization last March and an updated environmental assessment in December DOE permitted Fast LNG’s non-FTA shipments until 2029 NFE could request a review to extend the permitted term through 2050 once it has a “more complete record” to evaluate export projects Non-FTA authorization is usually considered essential for large-scale LNG export projects because of the flexibility in the customer base While an FTA permit gives an exporter access to customers in 20 countries including Asian buyers in Singapore and South Korea non-FTA approval makes far more demand centers available and makes a project more attractive to financial backers and large portfolio players With the first cargo from Fast LNG 1 nearing its destination in southern Baja California and a non-FTA permit secured CEO Wes Edens said NFE is a step closer to expanding its reach in the global market as it grows LNG export capacity in Mexico “This important authorization cements NFE’s position as a leading global vertically integrated gas-to-power company and enhances the marketability of our FLNG 1 asset,” Edens said “NFE is now able to freely supply cheaper and cleaner natural gas to underserved markets across the world and further our goal of accelerating the world’s energy transition.” Jacob Dick joined the NGI staff in January 2022 and was promoted to Senior Editor He previously covered business with a focus on oil and gas in Southeast Texas for the Beaumont Enterprise Jacob is a native of Kentucky and holds a bachelor’s degree in journalism from Western Kentucky University the first natural gas export project in the country remains on track to begin commercial operations by mid-year has secured a $3 billion loan from 19 banks for development of its CP2 export terminal in Louisiana Eni SpA is betting big on natural gas investments to build a robust international LNG portfolio from South America to the Middle East that can help buoy its long-term cash flows Golden Pass LNG Terminal LLC has received federal approval to commission major liquefaction components at its Texas export project signaling the next major addition of Gulf Coast feed gas demand Rising natural gas production is expected to meet LNG and industrial demand growth this summer while more renewable generation may help satisfy light power sector demand driven by mild weather and fundamentals create a relatively flat scenario for natural gas this summer Mexico’s state energy giant Petróleos Mexicanos (Pemex) has opened the door to the private sector to add financial and technical muscle as the company struggles with dropping oil and natural gas production Believing that transparent markets empower businesses Natural Gas Intelligence (NGI) provides natural gas price transparency and key news and data for the North American energy markets Altamira Therapeutics announced its transition from NASDAQ to OTCQB marketplace following a delisting notice from the Nasdaq Hearings Panel on December 18 results from the company's failure to maintain the required minimum bid price of $1.00 per share under Nasdaq's Rule 5550(a)(2) The company will continue trading under the ticker symbol CYTOF on the OTCQB platform ensuring uninterrupted market activity for shareholders with no action required Altamira had previously received a delisting notification on September 30 and appealed to present its compliance plan Altamira Therapeutics ha annunciato la sua transizione dal NASDAQ al mercato OTCQB a seguito di un avviso di delisting ricevuto dal Nasdaq Hearings Panel il 18 dicembre 2024 è dovuto al mancato rispetto del prezzo minimo di offerta richiesto di $1,00 per azione ai sensi della Regola 5550(a)(2) del Nasdaq L'azienda continuerà a essere quotata con il simbolo CYTOF sulla piattaforma OTCQB assicurando un'attività di mercato continua per gli azionisti senza necessità di alcuna azione Altamira aveva precedentemente ricevuto una notifica di delisting il 30 settembre 2024 e aveva presentato appello per esporre il proprio piano di conformità che è stato successivamente respinto dal Panel Altamira Therapeutics anunció su transición del NASDAQ al mercado OTCQB tras recibir un aviso de deslistado del Panel de Audiencias de Nasdaq el 18 de diciembre de 2024 efectivo a partir del 20 de diciembre de 2024 se debe a la incapacidad de la compañía para mantener el precio mínimo de oferta requerido de $1.00 por acción según la Regla 5550(a)(2) de Nasdaq La empresa continuará cotizando bajo el símbolo CYTOF en la plataforma OTCQB asegurando una actividad de mercado ininterrumpida para los accionistas sin necesidad de tomar ninguna acción Altamira había recibido previamente una notificación de deslistado el 30 de septiembre de 2024 y apeló para presentar su plan de cumplimiento Altamira Therapeutics는 2024년 12월 18일 나스닥 청문 위원회로부터 받은 상장 폐지 통지를 계기로 나스닥에서 OTCQB 시장으로 전환한다고 발표했습니다 2024년 12월 20일 발효되는 이 상장 폐지는 회사가 나스닥의 규정 5550(a)(2)에 따른 주당 최소 입찰가 $1.00을 유지하지 못한 결과입니다 회사는 OTCQB 플랫폼에서 CYTOF라는 티커 기호로 계속 거래될 예정이며 준수 계획을 제출하기 위해 항소했지만 궁극적으로 위원회에 의해 거부되었습니다 Altamira Therapeutics a annoncé sa transition du NASDAQ vers le marché OTCQB suite à un avis de radiation émis par le panel d'audition du Nasdaq le 18 décembre 2024 est due au non-respect du prix d'offre minimum requis de 1,00 $ par action conformément à la règle 5550(a)(2) du Nasdaq L'entreprise continuera d'être cotée sous le symbole CYTOF sur la plateforme OTCQB garantissant une activité de marché ininterrompue pour les actionnaires sans qu'aucune action ne soit requise Altamira avait auparavant reçu une notification de radiation le 30 septembre 2024 et avait fait appel pour présenter son plan de conformité dass es vom NASDAQ zum OTCQB-Markt wechselt Dezember 2024 eine Abmeldung durch das Nasdaq Hearings Panel erhalten hatte Dezember 2024 in Kraft und resultiert aus der Nichterfüllung des erforderlichen Mindestangebotspreises von $1,00 pro Aktie gemäß der Regel 5550(a)(2) von Nasdaq Das Unternehmen wird weiterhin unter dem Tickersymbol CYTOF auf der OTCQB-Plattform gehandelt wodurch den Aktionären eine ununterbrochene Marktaktivität ohne erforderliche Maßnahmen gewährleistet wird September 2024 eine Abmeldbenachrichtigung erhalten und hatte Berufung eingelegt The delisting from NASDAQ to OTCQB represents a significant downgrade in Altamira Therapeutics' market status and visibility lower institutional investor participation and potentially higher trading spreads The company's inability to maintain the $1.00 minimum bid price requirement signals underlying financial challenges The decision to avoid a reverse stock split doesn't address the fundamental issue of low market valuation the company's small size and OTC status may limit its ability to raise capital efficiently this transition typically means increased trading difficulty potentially higher transaction costs and fewer broker-dealers willing to make markets in the stock In simpler terms: Think of this like a store moving from a premium shopping mall (NASDAQ) to a less prominent location (OTCQB) it gets less foot traffic and might find it harder to attract premium customers and secure financing Hear@altamiratherapeutics.com (“Altamira” or the “Company”) (Nasdaq:CYTO) today provided a business update and reported its first half 2024 financial results "We are excited to continue to gain momentum with our new core activities in RNA delivery," commented Thomas Meyer recently published in a top-ranking scientific journal show dramatic reductions in sarcoma and breast cancer growth following treatment with Zbtb46 mRNA delivered with our SemaPhore nanoparticle technology The antitumor effect was further augmented when combined with anti-PD1 treatment These impressive outcomes add to the growing body of evidence supporting the great potential of RNA therapeutics and the ability of our platform to deliver RNA molecules effectively and safely into target cells outside the liver especially in cancer and inflammatory diseases.”   Meyer added: “We are progressing with the development of both the OligoPhore and the SemaPhore platforms as well as with our AM-401 and AM-411 flagship programs in KRAS driven cancers and in rheumatoid arthritis benefiting from our new access to laboratory space at the Switzerland Innovation Park in the Basel area we are evaluating our platforms for use in cardiac regeneration and for mRNA vaccines in joint projects with two partners and pursuing additional collaboration opportunities with other pharma and biotech companies we keep working towards completion of our strategic repositioning around RNA delivery through partnering of our legacy assets in inner ear therapeutics thanks to the recent public offering of shares we have been able to strengthen our financial position for our transition to a much less capital-intensive business model based on contract development and licensing of our RNA delivery technology.”   Research and development activities in Altamira’s core business of RNA delivery – built on its peptide based OligoPhore™ and SemaPhore™ nanoparticle platforms – continue to progress The key focus is on nanoparticle formulation and process development around the platforms the evaluation and development of nanoparticles for delivery of specific siRNA or mRNA payloads for collaboration partners and the two flagship programs AM-401 or AM-411 for treatment of KRAS driven cancers and rheumatoid arthritis (RA) Evidence for the effectiveness and versatility of Altamira’s RNA delivery platforms keeps growing as shown by two recent scientific publications:  Altamira’s own development work has resulted in significant enhancement of nanoparticle stability which has been one of the key challenges in the handling and transport of RNA formulations Thanks to its new flow process production method the Company obtained formulations of OligoPhore nanoparticles which are stable in liquid form when stored at 4°C for a period of at least one month able to withstand shaking stress without significant physicochemical changes The ability of nanoformulations to maintain their attributes during shaking stress is essential for transportation and one of the key limitations of lipid nanoparticles the most common type of RNA delivery vehicles For its proprietary development programs AM-401 and AM-411 Altamira filed in the first half of 2024 patent applications with the US Patent and Trademark Office These aim to complement the existing intellectual property and extend the duration of protection coverage of different KRAS mutations in cancer treatment with nanoparticles comprising the OligoPhore platform and a single siRNA sequence In vitro data confirmed the ability of polyKRASmut siRNA to knock down KRAS carrying the following mutations: G12C which account for the majority of KRAS mutations in pancreatic coverage of nanoparticles comprising siRNA sequences targeting the p65 protein a component of the NF-κB transcription factor Activation of p65 has been observed in multiple types of cancer as well as in many inflammatory diseases p65 is a well-known key checkpoint in RA inflammation and thought to regulate cell proliferation The Company aims to advance both AM-401 and AM-411 to an Investigational New Drug (IND) filing with the Food and Drug Administration (FDA) in 2026 and to out-license them either following the IND or after a Phase 1 clinical trial at the latest Altamira is pursuing with the RNA delivery business a ‘picks and shovels’ strategy based on the licensing of its platform technology to partners in the biotech and pharma industry for use in their own RNA drug product development programs The first such collaborations have been set up: Upon positive outcomes from these evaluations Altamira and its partners intend to discuss and negotiate licensing agreements Through its business development activities the Company is pursuing additional collaboration opportunities with other pharma and biotech companies The Company’s associate Altamira Medica AG (“Medica”) made further progress on implementing its growth strategy with Bentrio® With two of its international distributors it recently agreed on the expansion of their exclusive distribution territories: discussions and negotiations for distribution in the US The efficacy and safety of Bentrio has been demonstrated in a total of four clinical trials Results from the largest among them (the “NASAR” study) which enrolled 100 patients suffering from seasonal allergic rhinitis in Australia were recently published in a peer reviewed article in one of the leading scientific journals in allergology.3 In NASAR participants self-administered either Bentrio or saline nasal spray for two weeks 3 times per day The study showed a statistically significant reduction in the mean daily reflective Total Nasal Symptom Score (rTNSS) for Bentrio compared to saline (p = 0.013) as well as a statistically highly significant improvement in health-related quality of life (Rhinoconjunctivitis Quality of Life Questionnaire p < 0.001) and superior global ratings of efficacy by patients and investigators alike (p < 0.001) Bentrio showed good safety and tolerability and fewer Bentrio treated patients used relief medication and more of them enjoyed symptom-free days compared to saline treatment In the context of its strategic pivot towards RNA delivery Altamira divested in November 2023 a 51% stake in Medica to a Swiss private equity investor for a cash consideration of approximately $2.3 million Altamira will be entitled to receive 25% of the future licensing income of Medica and of Medica’s value appreciation in case of a sale which captures an additional share of the business’ upside potential Altamira continues to work towards the partnering of its inner ear therapeutics assets which – in the traditional oral formulation – is the standard of care treatment for vertigo in many countries around the world A phase 2 clinical trial in Europe demonstrated that a four-week treatment course with AM-125 in AVS patients was well tolerated and helped to accelerate vestibular compensation enabling patients to regain balance and recover faster where oral betahistine exceptionally has not been marketed for decades Altamira received in summer 2023 IND clearance from the FDA for a phase 2 clinical trial in benign paroxysmal positional vertigo (BPPV) BPPV accounts for 17 to 42% of all diagnosed cases; U.S healthcare costs associated with the diagnosis of BPPV alone approach $2 billion per year.4 Continued simplification of group structure Following the partial divestiture of the Bentrio activities in late 2023 Altamira has continued its efforts to simplify its corporate structure and align it with the strategic repositioning around its RNA delivery platform The Company transferred its Irish subsidiary Auris Medical Ltd to Altamira Medica AG and merged two of its subsidiaries in Basel (Switzerland) Auris Medical AG and Altamira Therapeutics AG The merged entity is called Altamira Therapeutics AG and continues to serve as the core operating subsidiary of the Company the Altamira Group comprises the parent company Altamira Therapeutics Ltd and its subsidiaries Altamira Therapeutics AG (Basel Switzerland) as well as the associated company Altamira Medica AG (Basel First Half 2024 Financial Results and Outlook Following the partial divestiture of the Bentrio business related activities have been reclassified and are reported as discontinued operations Continuing operations thus comprise the RNA delivery development programs as well as those related to AM-125 The financial results are reported for the first time in US dollars which the Company adopted as its new presentation currency Altamira expects total cash needs in 2024 to be in the range of $5.8 million to $7.0 million the Company raised $0.7 million from share issuances under the 2022 Commitment Purchase Agreement with Lincoln Park Capital Fund and gross proceeds of $4.0 million upfront from a public offering of common shares with milestone-linked warrants First Half 2024 and Business Update Conference Call & Webcast Details EDT its business update and first half 2024 results and CEO Thomas Meyer and COO Covadonga Pañeda will deliver prepared remarks followed by a Q&A session where they will address questions from investors and analysts A replay of the call will be available after the live event and accessible through the webcast link: https://edge.media-server.com/mmc/p/4wp8659n Consolidated Statement of Profit or Loss and Other Comprehensive Income/(Loss) For the six months ended June 30 1) Amounts have been re-presented from those previously published to reflect the change in the Company’s presentation currency from Swiss francs to US dollars 2) Revised for the reclassification of certain activities as discontinued operations 3) Weighted average number of shares outstanding: first half 2024: 2,060,714; first half 2023: 209,955 Consolidated Statement of Financial Position As of June 30 but are not limited to the clinical utility of Altamira’s product candidates Hear@altamiratherapeutics.com 1 Kabir AU et al. (2024), ZBTB46 coordinates angiogenesis and immunity to control tumor outcome, Nat Immunol https://www.nature.com/articles/s41590-024-01936-4 5 Altamira Medica was deconsolidated and classified as associate upon its partial divestiture in November 2023 The page you are looking for might have been removed Stoneshield is to develop a large data center campus outside Santander in northern Spain The government of Cantabria this week announced investment firm Stoneshield and its XDC Properties subsidiary were planning a campus in the area The Altamira project will see €3.6 billion ($3.37bn) invested and over 637,000 sqm (6.8 million sq ft) developed in the Vipar Society industrial estate across the municipalities of Piélagos and Villaescusa The campus will consist of 12 data center modules of 40MW each It will reportedly be developed in three phases; the first 100MW phase is set to start work in January 2026 for a 2032 launch while work on the next phases (totaling 500MW) will begin in 2028 The site will also include ​​75,000 square meters (807,293 sq ft) of photovoltaic panels to supply renewable energy to the campus Cantabria is an autonomous community and province in northern Spain with Santander as its capital city Meta’s upcoming Anjana cable is set to land in Santander said the project will position the community "as one of the main technological hubs in Europe XDC says it has up to 1GW of potential capacity across sites in Spain and Italy Quark Engineering has been appointed technical advisor to XDC Properties for the project Data Centre Dynamics Ltd (DCD), 32-38 Saffron Hill, London, EC1N 8FH Email. [email protected]DCD is a subsidiary of InfraXmedia energy infrastructure player New Fortress Energy (NFE) has celebrated the first liquefied natural gas (LNG) production from its floating LNG (FLNG) facility which is made up of three repurposed jack-up rigs off the coast of Altamira The start of liquefaction operations at New Fortress Energy’s initial 1.4 million tons per annum (mtpa) Fast LNG installation, FLNG 1 is said to establish the asset as “the fastest large-scale LNG project ever developed,” which is expected to assist in creating a new FLNG hub off the east coast of Mexico This development has been brought to life in partnership with CFE pairing the advancements in modular liquefaction technology with jack-up rigs or similar offshore infrastructure to enable a faster deployment schedule than traditional liquefaction facilities Chief Financial Officer of New Fortress Energy commented: “We are immensely proud of the dedication and hard work by our team who have completed more than 9 million work hours to bring this large-scale project to life at a record pace our downstream customers now benefit from additional access to clean and reliable LNG enabling sustained growth well into the future.” The project, which entails the deployment of Fast LNG liquefaction infrastructure to help expand the natural gas supply to Baja California Sur will liquefy gas supplied by the Sur de Texas-Tuxpan pipeline With a production capacity of approximately 70 TBtus FLNG is perceived to complete the vertical integration of NFE’s LNG portfolio The export permit for the Altamira Fast LNG facility from Mexico’s Ministry of Energy (SENER) enables the U.S company to export up to 7.8 million metric tons through April 2028 Department of Energy (DOE) for export of United States-sourced LNG to Mexico and other FTA countries which intends to deploy multiple FLNG units of 1.4 mtpa explains that the project adds more than $2 billion of infrastructure to its asset base the project is anticipated to play a pivotal role in supplying low-cost Chairman and CEO of New Fortress Energy highlighted: “First LNG represents a transformative moment for our company and the industry as a whole and reaffirms our position as a fully integrated leader in the global LNG market.” Daily news and in-depth stories in your inbox Ingersoll Rand Engineering Project Solutions At Ingersoll Rand’s Engineering Project Solutions we have been managing and implementing engineered to-order air packages for complex technical requirements for over 60 years We provide specialized custom compressed air and gas compressors as well as nitrogen generation packages to international EPC contractors and engineering companies across a range of […] energy infrastructure player New Fortress Energy (NFE) has restarted production at its floating liquefied natural gas (FLNG) unit off the coast of Altamira Shortly after the start of production at NFE’s inaugural Fast LNG installation, FLNG 1, and its first LNG cargo transported by Energos Infrastructure’s Energos Princess LNG carrier (LNGC) to Mexico’s terminal for unloading the unit was slated to undertake a scheduled maintenance program encompassing three repurposed jack-up rigs off the coast of Altamira with a capacity of 1.4 million tons per annum (mtpa) was expected to be out of commission for several days the unit was still scheduled to return to production mode and reach full production later during the month the scheduled maintenance outage of the 1.4 mtpa Fast LNG 1 asset has been completed and the FLNG unit returned to production on August 19 The company underlines that the FLNG 1 unit is expected to continue its production ramp-up before reaching full production later this month NFE has set the wheels in motion to expand the project by completing its previously announced $700 million loan for its second unit with construction works due to be finished in the first half of 2026 company can export up to 7.8 million metric tons through April 2028 from the Altamira Fast LNG facility The export permit was granted by Mexico’s Ministry of Energy (SENER) once the project got the green light from the U.S Department of Energy (DOE) for the export of United States-sourced LNG to Mexico and other free trade agreement (FTA) countries The SOD2 mRNA delivered with SemaPhore technology showed improved survival rates for mice with abdominal aortic aneurysm A new published study has shown that Altamira Therapeutics‘ SemaPhore technology used with superoxide dismutase 2 (SOD2) mRNA has successfully treated abdominal aortic aneurysm (AAA) in a mouse model Preclinical data showed a significant reduction in aorta dilation and a highly significant improvement in survival rates compared to untreated controls in mice with AAA who had been treated with SOD2 mRNA delivered systemically with peptide-based nanoparticles Altamira’s SemaPhore technology uses nanoparticles to deliver mRNA – specific genetic instructions – into cells These nanoparticles protect the mRNA as it travels through the body and help it enter the target cells An AAA is a localised enlargement of the lower part of the aorta the major blood vessel that supplies blood to the body This can lead to life-threatening internal bleeding if it ruptures SOD2 is an enzyme that reduces harmful reactive oxygen species (ROS) high ROS levels cause inflammation and damage to the artery wall which can slow AAA progression and prevent rupture The company was founded in 2003 and is headquartered in Hamilton It currently has two preclinical siRNA programmes which use its SemaPhore technology: AM-401 for KRAS-driven cancer and AM-411 for rheumatoid arthritis Altamira’s chief scientific officer and co-author of the study Samuel Wicklin said: “Using SOD2 mRNA to modulate oxidative stress appears a very promising approach in various challenging cardiovascular disorders such as abdominal aortic aneurysm or atherosclerosis and in other inflammatory or degenerative disease where ROS is a critical disease driver.” Don’t let policy changes catch you off guard Stay proactive with real-time data and expert analysis A spotlight has been on nanomedicine following the success of lipid nanoparticle-based Covid-19 vaccines. In January 2024, Roche’s Genentech teamed up with biotech GenEdit to use the latter company’s non-viral delivery platform for gene editing therapies non-lipid hydrophilic nanoparticles (HNPs) for targeted in vivo delivery nanoparticles are also used in diagnostics Researchers at the Massachusetts Institute of Technology (MIT) recently developed a new lung cancer test where patients inhale nanoparticles from a nebuliser or asthma inhaler and then test their urine on a paper test strip The team plans to conduct clinical trials in the future mRNA vaccine coverage on Pharmaceutical Technology (Or Clinical Trials Arena)  is supported by Trilink. Editorial content is independently produced and follows the highest standards of journalistic integrity Topic sponsors are not involved in the creation of editorial content Please check your inbox to download the Whitepaper By downloading this Whitepaper, you acknowledge that GlobalData may share your information with Trilink Thematic and that your personal data will be used as described in their Privacy Policy Give your business an edge with our leading industry insights View all newsletters from across the GlobalData Media network New Fortress Energy‘s Fast LNG facility off Altamira, Mexico is operating above its nameplate capacity, delivering nine LNG cargoes since its commissioning over the summer the FLNG 1 facility has achieved production rates of 1.67 MTPA operating at 120% of its designed capacity Department of Energy last year authorized NFE to export up to 1.4 million tonnes per annum of LNG to non-Free Trade Agreement countries for a five-year term complementing existing approvals for Free Trade Agreement nations The facility represents the first of two FLNG production units in NFE’s Altamira export project natural gas through the Sur de Texas-Tuxpan pipeline FLNG 1 holds the distinction of being the only LNG liquefier in the Gulf Coast region authorized to export to Puerto Rico A 2024 U.S. Customs and Border Protection ruling allows NFE to transport U.S.-sourced LNG using non-U.S qualified vessels without violating the Jones Act Commissioning of the FLNG 2 facility is expected in the first half of 2027 Sign up for gCaptain’s newsletter and never miss an update and updates delivered daily straight to your inbox The Trump administration took steps to impose levies on Chinese vessels docking at US ports threatening to shake up global shipping routes and escalate the trade war between the world’s two biggest economies Liner shipping association the World Shipping Council (WSC) has raised significant concerns about the newly announced U.S warning of potential adverse effects on American trade.. the final USTR plan softens fee levels and offers exemptions and incentives aiming to curb Chinese dominance without crippling global trade flows Subscribe to gCaptain Daily and stay informed with the latest global maritime and offshore news Stay informed with the latest maritime and offshore news For general inquiries and to contact us,please email: [email protected] To submit a story idea or contact our editors, please email: [email protected] For advertising opportunities contactEmail: [email protected]Phone: +1.805.704.2536 Essential news coupled with the finest maritime content sourced from across the globe In a new year’s rollout of Dutch-market buys, HarperCollins Holland names four Gottmer imprints being acquired in the Netherlands. Key titles from the Gottmer Uitgevers Groep imprint Hollandia being acquired by HarperCollins Holland. These books are from a collection focused on adventure travel. Image: Hollandia By Porter Anderson, Editor-in-Chief | @Porter_Anderson according to HarperCollins will further expand what it sees as a “fast-growing position in the trade book market in the Netherlands and Belgium.” have more than 125 combined years of publishing history “They hold leading positions in their respective markets,” today’s media messaging says, “with successful bestselling authors, a strong content pool, and exceptional brand awareness. As part of the deal, Vaarbewijs Academy will also join the HarperCollins Holland portfolio The addition of these four lifestyle imprints will expand the HarperCollins Holland nonfiction portfolio to include categories such as cooking HarperCollins Holland’s managing director and Hollandia have an impressive publishing history and have become strong brands in their own right “We’re proud to welcome these brands and their fantastic supporting team members under the umbrella of the HarperCollins publishing group and look forward to shaping the future of the publishing house together.” Chantal Restivo-Alessi HarperCollins’ chief digital officer and international foreign language CEO saying: “Holland is a key market in our international portfolio and one in which we see great growth opportunities “This acquisition will allow us to increase our market share and position us for continued growth in the market.” Following its divestment of these properties Gottmer is expected to focus entirely on the children’s book market the business director of Gottmer Uitgevers Groep “In HarperCollins we’ve found a party that can allow the lifestyle imprints and employees to flourish further “For our own organization, this step means that we will focus on the titles and characters of Gottmer children’s books and [imprint] Big Balloon we have a clear ambition to further increase reading pleasure among young people.” is one of the most internationalized of the Big Five publishers with operations in 15 nations and an annual output of some 10,000 books in 16 languages HarperCollins Holland publishers roughly 100 new trade books and 150 new Pocket Series titles annually under its imprints HarperCollins HarperCollins Holland is based in Amsterdam and currently employs more than 35 people The Gottmer Group is one of the Netherlands’ leading children’s book publishers publishing characters and series Dikkie Dik More from Publishing Perspectives on mergers and acquisitions is here, more on international publishing is here, and more on the Netherlands’ market is here Porter Anderson has been named International Trade Press Journalist of the Year in London Book Fair's International Excellence Awards He is Editor-in-Chief of Publishing Perspectives He formerly was Associate Editor for The FutureBook at London's The Bookseller Anderson was for more than a decade a senior producer and anchor with CNN.com which now is owned and operated by Jane Friedman Δdocument.getElementById( "ak_js_1" ).setAttribute( "value" energy infrastructure player New Fortress Energy (NFE) has completed the first cargo load and sail operation at its floating liquefied natural gas (FLNG) unit off the coast of Altamira The first LNG cargo comes days after the start of production at NFE’s inaugural Fast LNG installation which is made up of three repurposed jack-up rigs off the coast of Altamira with a capacity of 1.4 million tons per annum (mtpa) Since the start-up was originally expected to occur at the beginning of the second quarter the delays in placing the FLNG 1 project into service have been estimated to cost the firm approximately $150 million per quarter in lost operating margin “We’re excited to announce first cargo load & sail at our first Fast LNG project The first cargo has been loaded onto the Energos Princess and will be delivered to our La Paz We’re excited to begin supplying our customers with our own LNG – a significant milestone for our company and the world of LNG,” highlighted New Fortress Energy Energos Infrastructure’s Energos Princess LNG carrier (LNGC) is now on its way to Mexico’s terminal to unload the first cargo The FLNG is due to undertake a scheduled maintenance program it will be out of commission with the outage expected to last for several days The unit will resume operations and reach full production later this month Recently, NFE completed its previously announced $700 million loan for its second unit, FLNG 2 with construction works slated to be finished in the first half of 2026 company has received the all-clear to export up to 7.8 million metric tons through April 2028 from the Altamira Fast LNG facility The export permit came from Mexico’s Ministry of Energy (SENER) after the project secured authorization from the U.S This content is available after accepting the cookies once a floating storage and regasification unit (FSRU) arrived at the scene (NFE) has reportedly achieved first LNG at its export terminal offshore of Altamira indicating it could be close to loading Mexico’s first export cargo coincided with the company’s guidance that it could begin loading cargoes in mid-July the company disclosed it had achieved its goal of achieving the fastest timeline from construction to first LNG for a large-scale export facility with the start of liquefaction at Altamira “First LNG represents a transformative moment for our company and the industry as a whole and reaffirms our position as a fully-integrated leader in the global LNG market,” CEO Wes Edens said Crews last summer began installing the floating modules offshore the state of Tamaulipas Gas connections to existing infrastructure near the existing import terminal at Altamira were completed in November [Check out a Special Edition of NGI's Daily Gas Price Index, 'Ports Unknown,' to delve into the price impacts of new LNG supplies, and where those supplies will be needed most later this decade and beyond. Download now.] In late April, NFE reported a malfunction with the facility’s cold box that resulted in some minor injuries and released perlite that was being used during system testing The issue further delayed the facility’s first export NGI’s forward fixed prices at Agua Dulce for August delivery were $1.697/MMBtu as of Friday, versus $1.65 for the summer balance. Summer 2025 prices were trading at $2.644. Agua Dulce basis prices were quoted 54.4 cents below Henry Hub for summer 2024 and 47.8 cents below the benchmark for summer 2025 While NFE is nearing its next milestone for the project analysts with Wood Mackenzie noted that it could take several more weeks for the Energos Princess to actually leave Altamira’s anchorage with a tanker full of LNG “Considering the project’s evolution in the past year or so we do not rule out a new delay that could push Altamira’s first commercial LNG shipment to August,” analysts wrote in a recent note there are a few possible destinations for Mexico’s first export cargo NFE previously received a permit to export to FTA countries, allowing it to ship volumes to its existing customers in Puerto Rico or to import facilities in the United States. U.S. Customs and Border Protection ruled earlier this year that transportation of LNG produced offshore Altamira by non-U.S. qualified vessels would not violate the Jones Act Altamira is one of at least seven commercially advanced projects in the United States and Mexico with a pending application for a non-free trade agreement (FTA) permit impacted by the Department of Energy’s pause on new authorizations 43,000+ global companies doing business in the region. 102,000+ key contacts related to companies and projects Analysis, reports, news and interviews about your industry in English, Spanish and Portuguese. Highlights: A new target has been defined at Serafim located 2km east of the existing Mineral Resource where rock chip sampling identified a hydrothermal breccia containing clasts of veined porphyry intrusive This included a grab rock sample+ of 5.6 g/t gold a grab rock sample returned an assay of 7.8 g/t gold with all 10 rock chip samples averaging 3.2 g/t gold and with all samples recording greater than 1g/t gold A 50-metre trench outlined three mineralized intervals within which 31 metres averages greater than 0.25 g/t gold (peak value 1m at 6.5 g/t gold) with the mineralization open at both ends of the trench Trenching at the Guillermo prospect has returned two intervals defining future drill targets within quartz veined and altered volcanic host rocks with a coherent interval of 35 metres at 0.5 g/t gold CEO Mike Bennett commented; “Our ongoing field program of soil sampling continues to successfully define new targets Our recent discovery of further evidence of porphyry-related gold mineralization at Serafim brings the current inventory of new drill target areas in the Cajueiro project This latest discovery remains at a very early stage but is a very positive indicator and supports our thesis that the district-scale gold occurrences identified to date over an east-west distance of 14km are most likely part of the same porphyry-related mineralizing event within this expanding gold district The results from Tavares Norte and Guillermo also define drill targets on extensive zones of surface gold mineralization.” The Cajueiro project is located approximately 75km NW of the town of Alta Floresta in the state of Mato Grosso western central Brazil lies on open farmland and has grid power and a local water supply Cajueiro is the most advanced of three key projects that Altamira controls in the region the other two being Apiacas and Santa Helena The Cajueiro Central project has current NI 43-101 resources* of 5.66Mt at 1.02 g/t gold for a total of 185,000 oz in the Indicated Resource category and 12.66Mt at 1.26 g/t gold for a total of 515,000 oz in the Inferred Resource category (estimated using a gold price of US$1,500/oz) Reconnaissance drilling at the Maria Bonita target located 7km west of the Cajueiro Central Mineral Resource identified the first porphyry-hosted gold discovery at Cajueiro and returned gold values up to 146m at 1g/t gold (from 23 metres depth) soil sampling and proprietary drone magnetics continues to develop new targets in the Cajueiro district An east-west corridor of intrusive-related prospects lies between major structures that were later reactivated and intruded by regional-scale gabbro dykes that extend over tens of kilometres there are five prospects from Novo Sonho in the west to Guillermo in the east lies the Cajueiro Mineral Resource and two active prospects at Espirro and Serafim two trenches have been excavated and sampled The underlying rocks are sericite altered tuffs interpreted as overlying a mineralizing felsic intrusive at shallow depth The Tavares Norte prospect is located 1km NW of the central resource area The current soil anomaly extends for some 1,300 metres x 1,800 metres and small felsic intrusives are interpreted to underlie the soil anomaly Surface rock chip grab sampling+ across the prospect returned an average grade of 3.2 g/t gold from 10 samples with a highest value of 7.8 g/t gold A single trench was excavated alongside a dirt road traversing the anomaly in a north-east direction in the eastern sector of the prospect and returned three intervals of interest; 23 metres at 0.25 g/t gold 2 metres at 3.27 g/t gold and 6 metres at 0.38 g/t gold located 1,000 metres north of the central resource area 8 additional grab rock chip samples+ returned an average of 0.28 g/t gold with a peak value of 0.71 g/t gold and all samples returning greater than 0.1 g/t gold A single drill hole completed in 2017 intersected 65 metres of intrusive breccia containing dominantly volcanic wall-rock clasts Trenching at Guillermo has defined two zones of interest for drill testing The rocks exposed in the trenches are felsic volcanics intruded by small stocks or dykes of altered and veined felsic igneous rocks Results received to date include 35 metres at 0.45 g/t gold 7 metres at 0.22 g/t gold and 7.6 metres at 0.41 g/t gold These results demonstrate that the intrusive rocks carry anomalous gold and warrant drill testing to confirm the subsurface continuity and grade trend of the trench intervals Soil sample and drone magnetic results are pending over parts of the grid In a similar manner to the Maria Bonita area mineralized porphyry intrusives are cut by later barren phases of the inferred same felsic intrusive suite Dating studies are ongoing to better interpret the age relationships Grab sampling+ of float breccia boulders at the Serafim prospect returned one sample containing 5.57 g/t gold This sample is a breccia containing clasts of quartz veined porphyry intrusive which are interpreted to have been derived from the roof zone of a porphyry intrusive These new results underline the emerging context of a set of porphyry-related gold occurrences within a defined structural corridor that shows evidence of at least four episodes of multiphase intrusive activity pointing to a deep and reactivated set of structurally controlled magma conduits with positive gold in soil and rock sampling now provide a set of targets for scout drilling to extend the inventory of mineralization outside the Cajueiro Central Mineral Resource and the Maria Bonita discovery The company is advancing six projects spanning over 100,000 hectares within the prolific Juruena Gold Belt-an area that has historically yielded 6 million ounces of placer gold a highly prospective asset with an NI 43-101 compliant resource estimate of 185,000 oz gold in the Indicated category (5.66Mt at 1.02 g/t) and an additional 515,000 ounces in the Inferred category (12.66Mt at 1.26 g/t) highlighting the region’s exceptional gold endowment and scalability is company that offers investors an opportunity to participate.. By Peter Kennedy Namib Minerals is set to become a publicly traded company in the U.S.,.. is a company that offers investors an opportunity into early-stage.. is entering a new growth phase as it moves to.. By Peter Kennedy Lack of available infrastructure has long been a perceived impediment to the development.. By Peter Kennedy The Golden Triangle mining district in northwestern British Columbia ranks among the richest.. + by their nature, grab samples are not representative of the bulk metal content of a mineralized zone. The Cajueiro project is located approximately 75km NW of the town of Alta Floresta in the state of Mato Grosso (Figure 1) in central western Brazil. The project is easily accessible by road, lies on open farmland and has grid power and a local water supply. Cajueiro is the most advanced of three key projects that Altamira controls in the region, the other two being Apiacas and Santa Helena (Figure1). Figure 1: Location of the Cajueiro, Apiacas and Santa Helena projects. To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/4500/248383_736f4da474588b09_001full.jpg The Cajueiro Central project has current NI 43-101 resources* of 5.66Mt @ 1.02 g/t gold for a total of 185,000 oz in the Indicated Resource category and 12.66Mt @ 1.26 g/t gold for a total of 515,000 oz in the Inferred Resource category (estimated using a gold price of US$1,500/oz). Reconnaissance drilling at the Maria Bonita target, located 7km west of the Cajueiro Central Mineral Resource, identified the first porphyry-hosted gold discovery at Cajueiro and returned gold values up to 146m @ 1g/t gold (from 23 metres depth) (see press release dated May 22, 2024). A program of mapping, soil sampling and proprietary drone magnetics continues to develop new targets in the Cajueiro district (Figure 2). An east-west corridor of intrusive-related prospects, lies between major structures that were later reactivated and intruded by regional-scale gabbro dykes that extend over tens of kilometres. Within this corridor, there are five prospects from Novo Sonho in the west to Guillermo in the east, over a distance of 12 km (Figure 2). To the south of this corridor, lies the Cajueiro Mineral Resource and two active prospects at Espirro and Serafim. *NI 43-101 Technical Report, Cajueiro Project, Mineral Resource Estimate: Global Resource Engineering, Denver Colorado USA, 10th October 2019; Authors K. Gunesch, PE; H. Samari, QP-MMSA; T. Harvey, QP-MMSA Figure 2: Cajueiro district targets (yellow labels) and their position in relation to the defined Mineral Resource at Cajueiro Central (white labels for sub-sectors). An alignment of six of the targets occur in close spatial association to a pronounced east-west fault corridor marked by later gabbroic dykes. https://images.newsfilecorp.com/files/4500/248383_736f4da474588b09_002full.jpg At Mombaque, two trenches have been excavated and sampled, totalling 380m. The underlying rocks are sericite altered tuffs, interpreted as overlying a mineralizing felsic intrusive at shallow depth. Results are pending. Table 1: Tavares Norte trench results, based on 1 metre sample intervals. At Morro Verde, located 1000m north of the central resource area, 8 additional grab rock chip samples+ returned an average of 0.28 g/t gold, with a peak value of 0.71g/t gold and all samples returning greater than 0.1 g/t gold. A single drill hole completed in 2017, (see press release dated August 1, 2017) intersected 65m of intrusive breccia containing dominantly volcanic wall-rock clasts. Figure 3: Drillhole CJO-98, Morro Verde intrusive breccia. https://images.newsfilecorp.com/files/4500/248383_736f4da474588b09_004full.jpg Trenching at Guillermo has defined two zones of interest for drill testing. The rocks exposed in the trenches are felsic volcanics intruded by small stocks or dykes of altered and veined felsic igneous rocks (see press release dated December 11, 2024). Results received to date include 35m @ 0.45 g/t gold, 7m @ 0.22 g/t gold and 7.6m @ 0.41 g/t gold (see Table 2). These results demonstrate that the intrusive rocks carry anomalous gold and warrant drill testing to confirm the subsurface continuity and grade trend of the trench intervals. Table 2: Guillermo trench results, based on 1 metre sample intervals. Soil sample and drone magnetic results are pending over parts of the grid. In a similar manner to the Maria Bonita area, mineralized porphyry intrusives are cut by later, barren phases of the inferred same felsic intrusive suite. Dating studies are ongoing to better interpret the age relationships. Grab sampling+ of float breccia boulders at the Serafim prospect returned one sample containing 5.57 g/t gold. This sample is a breccia containing clasts of quartz veined porphyry intrusive which are interpreted to have been derived from the roof zone of a porphyry intrusive (Figure 4). + By their nature, grab samples are not representative of the bulk metal content of a mineralized zone. Figure 4: Clasts from surface rock chip sample in Serafim hydrothermal breccia https://images.newsfilecorp.com/files/4500/248383_736f4da474588b09_006full.jpg Figure 5: Silicified hydrothermal breccia from Serafim containing 0.2g/t gold https://images.newsfilecorp.com/files/4500/248383_736f4da474588b09_007full.jpg These new results underline the emerging context of a set of porphyry-related gold occurrences within a defined structural corridor that shows evidence of at least four episodes of multiphase intrusive activity, pointing to a deep and reactivated set of structurally controlled magma conduits. These favourable structural settings, with positive gold in soil and rock sampling, now provide a set of targets for scout drilling to extend the inventory of mineralization outside the Cajueiro Central Mineral Resource and the Maria Bonita discovery. Guillermo Hughes, FAIG and M AusIMM., a consultant to the Company as well as a Qualified Person as defined by National Instrument 43-101, supervised the preparation of the technical information in this news release. Ongoing exploration and fieldwork at Cajueiro indicate the presence of multiple porphyry gold systems, reinforcing its potential for district-scale development. These hard-rock gold sources align with historical alluvial gold production, highlighting the region's exceptional gold endowment and scalability. With a rich geological setting and a track record of significant discoveries, the Company is well-positioned to unlock further value across its expansive land package. ** Juliani, C. et al ; Gold in Paleoproterozoic (2.1 to 1.77 Ga) Continental Magmatic Arcs at the Tapajós and Juruena Mineral Provinces (Amazonian Craton,Brazil): A New Frontier for the Exploration of Epithermal-Porphyry and Related Deposits. Minerals 2021, 11, 714. https://doi.org/10.3390/min11070714 Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. The securities described herein have not been registered under the U.S. Securities Act or any state securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements under the U.S. Securities Act and any applicable state securities laws. Gold analysis has been conducted by SGS method FAA505 (fire assay of 50g charge), with higher grade samples checked by FAA525. Analytical quality is monitored by certified references and blanks. Until dispatch, samples are stored under the supervision the Company's exploration office. The samples are couriered to the assay laboratory using a commercial contractor. Pulps are returned to the Company and archived. Drill holes results are quoted as down-hole length weighted intersections. * NI 43-101 Technical Report, Cajueiro Project, Mineral Resource Estimate: Global Resource Engineering, Denver Colorado USA, October 10, 2019; Authors K. Gunesch, PE; H. Samari, QP-MMSA; T. Harvey, QP-MMSA To view the source version of this press release, please visit https://www.newsfilecorp.com/release/248383 Copyright © 2025 FactSet Research Systems Inc.© 2025 TradingView and other liquids including biofuels and natural gas liquids and projections integrated across all energy sources Financial market analysis and financial data for major energy companies and resources related to energy disruptions and infrastructure Regional energy information including dashboards Come test out some of the products still in development and let us know what you think Forms EIA uses to collect energy data including descriptions Sign up for email subscriptions to receive messages about specific EIA products Subscribe to feeds for updates on EIA products including Today in Energy and What's New Reports requested by congress or otherwise deemed important Retail prices for regular grade gasoline in California are consistently higher than in any other state in the continental United States often exceeding the national average by more than a dollar per gallon Several factors contribute to this high price crude oil prices generally decreased while U.S refinery margins initially increased before decreasing in the final month of the quarter we review petroleum markets price developments in 1Q25 and structurally lower debt needs have contributed to lower interest expenses for some publicly traded U.S despite the level of interest rates across the economy being relatively high imports of petroleum products decreased by 210,000 barrels per day (b/d) in 2024 to average 1.8 million b/d exports of total petroleum products increased to a record 6.6 million barrels per day (b/d) annual average petroleum product exports increased by 495,000 b/d as U.S while exports of total motor gasoline decreased decreased by 210,000 b/d in 2024 compared with 2023 The TIE was reposted to correct a data point In 2024, pipeline companies completed five pipeline projects to transport petroleum liquids in the United States, according to our recently updated Liquids Pipeline Projects Database The five projects consisted of three hydrocarbon gas liquid (HGL) pipelines and two petroleum product pipelines U.S. marketed natural gas production remained relatively flat in 2024, growing by less than 0.4 billion cubic feet per day (Bcf/d) compared with 2023 to average 113 Bcf/d, according to our latest Natural Gas Monthly Production growth in the Permian was offset by declining production in the Haynesville and relatively flat production in Appalachia U.S. crude oil production grew by 270,000 barrels per day (b/d) in 2024 to average 13.2 million b/d, according to our Petroleum Supply Monthly Almost all the production growth came from the Permian region U.S. energy consumption decreases in the next several years before increasing again in the early 2040s through 2050, according to our recently published Annual Energy Outlook 2025 (AEO2025) energy consumption in 2050 is lower than in 2024 in most of the scenarios we explore in AEO2025 but the range of outcomes varies significantly based on the underlying assumptions has hovered around 1.1 million barrels per day (b/d) since 2020 and we forecast it will remain about the same through 2026 crude oil exports in 2024 surpassed the previous record set in 2023 exceeding an annual average of 4.1 million barrels per day (b/d) crude oil export year-over-year growth slowed to 1% in 2024 The chemical maker resumed titanium dioxide production at its Altamira facility after Tropical Storm Alberto brought relief amid the country’s ongoing drought Retrieved from The Chemours Co The Chemours Co. resumed titanium dioxide production at its facility in Altamira, Mexico, after the local government lifted water intake restrictions, the chemical maker stated in a June 24 release Last month, the Mexico state of Tamaulipas’ government requested Chemours and other manufacturers in the Altamira area to minimize their water intake due to the country’s ongoing drought The restrictions affected at least six chemical company facilities in the area senior manager of global risk intelligence at software risk tracking company Everstream Analytics some of the affected chemical makers sent force majeure notices to their customers petrochemical company Saudi Basic Industries Corp. polymer producers M&G Polimeros and Vestolit and chemical company Cabot Corp However, Cabot plans to resume production of carbon black additives at its Altamira site soon, Plastics News reported Despite the ongoing drought, rains from Tropical Storm Alberto brought some relief to the affected area, generating a large flow of water from the upper basin of the Guayalejo-Tamesí River, the Mexico government said in a June 24 Facebook post Tamaulipas government officials said despite the significant recovery progress they must maintain measures for rational use of the water resources Get the free daily newsletter read by industry experts Drugmakers have been slow to adopt the production process which experts say can streamline operations boost data quality and reduce time to market The technology can make it easier for companies to use 3D printing and enhance the design process.  Subscribe to Manufacturing Dive for top news Want to share a company announcement with your peers The free newsletter covering the top industry headlines on the banks of the Xingu River (a tributary of the Amazon) is a geographic colossus that fascinates both for its vast territorial expanse and its natural and cultural wealth it is the largest municipality in Brazil and until 2009 it was the largest municipal subdivision in the world This extensive area is larger than 104 countries or the states of Florida and Missouri in the United States The title of the largest municipal subdivision in the world is now held by Qaasuitsup in Greenland with an impressive area of 660,000 square kilometers which even eclipses the vastness of Altamira The largest city in the world is considered to be the Chinese Hulunbuir almost the same size as the entire state of Texas although it is not very clear whether this corresponds to the city itself or its jurisdictional area encompassing 12.8% of Pará’s territory the area was inhabited by nomadic and semi-nomadic indigenous peoples The formal foundation of the city dates back to the 18th century with the creation of the Tavaquara Jesuit mission Altamira became a hub for rubber extraction and trade of Amazonian products so did its connections with the rest of the region agriculture and commerce play crucial roles in its economy the most significant change came with the construction of the Belo Monte Dam the fourth-largest hydroelectric dam in the world In terms of generation capacity, it is the third largest in the world with 11,233 GW, after the Three Gorges Dam in China, and the Itaipu Dam between Brazil and Paraguay It is widely known that the name Altamira comes from Spanish which still retained the Jesuit name Tavaquara was dominated by a merchant named Francisco Gayoso who during one of his trips to Europe heard about the newly discovered Altamira Cave in Cantabria (Spain) which contained astonishing cave paintings The vast expanse of Altamira hosts impressive biodiversity Part of its territory includes protected areas such as the Altamira National Forest which are vital for the conservation of the Amazon and its countless species a rainy season extending from November to June high temperatures are a constant throughout the year favoring lush vegetation that defines the region’s landscape Altamira has been in the news worldwide in recent years for negative records such as being the most violent city in Brazil strong opposition to the construction of the dam and the deforestation of the Amazon rainforest This article was first published on our Spanish Edition on June 7, 2024: Altamira, la ciudad brasileña cuyo territorio es más grande que 104 países Cantabria (Spain) has concluded that some of the artworks it contains could be much older… 43,000+ global companies doing business in the region news and interviews about your industry in English